Form 4 Tracker
CYTOKINETICS INC
CYTK

65 insider filings · Latest: Jun 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 3, 2024Sep 3 8:08 PMROBERT BLUM
Proposed Sale
5,000$57.03$285.1K

View →

Sep 3, 2024Sep 3 8:07 PMFADY MALIK
Proposed Sale
7,384$57.01$421.0K

View →

Aug 26, 2024Aug 26 8:14 PMB LYNNE PARSHALL
Proposed Sale
5,000$57.26$286.3K

View →

← Previous

Page 6 of 6

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 30, 2026Apr 30 8:22 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2654,000(D)

View →

Apr 21, 2026Apr 21 8:22 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8054,886(D)

View →

Apr 7, 2026Apr 8 8:18 PMFady Ibraham MalikEVP Research & Development
Option Exercise
4,500$10.600(D)

View →

Mar 15, 2026Mar 17 8:11 PMRobert I BlumDirector, President & CEO
Grant/Award
113,529$60.06111,864(D)

View →

Mar 15, 2026Mar 17 8:08 PMAndrew CallosEVP, Chief Commercial Officer
Grant/Award
31,145$60.0629,480(D)

View →

Mar 15, 2026Mar 17 8:06 PMJeffrey HessekielChief Legal & Admin Officer
Grant/Award
31,145$60.0622,820(D)

View →

Mar 15, 2026Mar 17 8:05 PMSung LeeEVP, Chief Financial Officer
Grant/Award
31,145$60.0629,480(D)

View →

Mar 15, 2026Mar 17 8:03 PMFady Ibraham MalikEVP Research & Development
Grant/Award
41,192$60.0639,527(D)

View →

Mar 5, 2026Mar 5 9:27 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
26,000$39.1369,000(D)

View →

Mar 2, 2026Mar 2 9:28 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
886$37.630(D)

View →

Feb 5, 2026Feb 6 1:17 AMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2684,000(D)

View →

Feb 2, 2026Feb 2 9:40 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
886$37.63886(D)

View →

← Previous

Page 2 of 2